首页 › 基金 › FRONTIER CAPITAL MANAGEMENT CO LLC › AXSM
FRONTIER CAPITAL MANAGEMENT CO LLC 对 AXSM 的持仓历史
AXSOME THERAPEUTICS INC. · 医疗保健
FRONTIER CAPITAL MANAGEMENT CO LLC 在 Q2 2026 的 13F 申报中披露持有 AXSM(AXSOME THERAPEUTICS INC.)254,280 股,市值约 US$62.2M,约占其申报组合的 0.58%,在其申报持仓中市值排名第 44 位。 FRONTIER CAPITAL MANAGEMENT CO LLC 最近 12 个申报季度中有 12 个季度披露了 AXSM 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
FRONTIER CAPITAL MANAGEMENT CO LLC 对 AXSM 的持仓演变
FRONTIER CAPITAL MANAGEMENT CO LLC 于 Q3 2023 首次披露 AXSM 持仓:160,676 股(约 US$11.2M)。 该持仓在 Q2 2026 达到峰值 254,280 股,市值约 US$62.2M。 在 12 次申报中,FRONTIER CAPITAL MANAGEMENT CO LLC 6 次增持、5 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 254,280 股、市值约 US$62.2M,环比增持 51,214 股。。 持仓曾出现大幅变动:Q4 2023 减持约 41% (随后一个季度股价基本持平)、Q4 2024 减持约 56% (随后一个季度股价上涨 38%)、Q3 2025 增持约 338% (随后一个季度股价上涨 50%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 160.68K | $11.23M | 新进 |
| Q4 2023 | 94.89K | $7.55M | 减持 |
| Q1 2024 | 105.34K | $8.41M | 增持 |
| Q2 2024 | 96.03K | $7.73M | 减持 |
| Q3 2024 | 120.54K | $10.83M | 增持 |
| Q4 2024 | 52.77K | $4.46M | 减持 |
| Q1 2025 | 43.26K | $5.05M | 减持 |
| Q2 2025 | 28.84K | $3.01M | 减持 |
| Q3 2025 | 126.38K | $15.35M | 增持 |
| Q4 2025 | 157.69K | $28.80M | 增持 |
| Q1 2026 | 203.07K | $34.32M | 增持 |
| Q2 2026 | 254.28K | $62.24M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AXSM 与 13F 数据
AXSM(AXSOME THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 AXSM,申报仓位最大的包括:Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AXSM 的基金
- Deep Track Capital, LP 700.00K 股 · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 648.76K 股 · $158.80M · Q2 2026
- Hood River Capital Management LLC 402.68K 股 · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K 股 · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K 股 · $73.43M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K 股 · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K 股 · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K 股 · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K 股 · $53.46M · Q2 2026
更多关于 FRONTIER CAPITAL MANAGEMENT CO LLC
常见问题
How long has FRONTIER CAPITAL MANAGEMENT CO LLC held AXSM?
FRONTIER CAPITAL MANAGEMENT CO LLC has disclosed AXSM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is FRONTIER CAPITAL MANAGEMENT CO LLC's current position in AXSM?
As of Q2 2026, FRONTIER CAPITAL MANAGEMENT CO LLC holds 254.28K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $62.24M, representing 0.58% of its reported portfolio and ranking #44.
Has FRONTIER CAPITAL MANAGEMENT CO LLC been buying or selling AXSM?
In the latest 13F filing (Q2 2026), FRONTIER CAPITAL MANAGEMENT CO LLC increased its position in AXSM. The position peaked in Q2 2026 at 254.28K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.